Yu Jen Jan

424 total citations
7 papers, 99 citations indexed

About

Yu Jen Jan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yu Jen Jan has authored 7 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Yu Jen Jan's work include Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (3 papers) and Molecular Biology Techniques and Applications (2 papers). Yu Jen Jan is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (3 papers) and Molecular Biology Techniques and Applications (2 papers). Yu Jen Jan collaborates with scholars based in United States and Taiwan. Yu Jen Jan's co-authors include Yazhen Zhu, Hsian‐Rong Tseng, Matthew Smalley, Li-Ching Chen, Hsiao‐hua Yu, Jie‐Fu Chen, Shuang Hou, Yi‐Tsung Lu, Jiantong Dong and Edwin M. Posadas and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Yu Jen Jan

7 papers receiving 98 citations

Peers

Yu Jen Jan

ONCOL

BE

CR

MB

PPCH

Erin Emmons United States

Bochra Zidi Switzerland

Adam Akkad United States

Ilinca M. Lungu Canada

Peter Bartosik United States

Netanel Loyfer Israel

William J. Barendt United Kingdom

Khaled Ibrahim Lebanon

E Barrow United Kingdom

Nikolay Belev Bulgaria

Erin Emmons United States

Yu Jen Jan

27 ×0.5

ONCOL

31 ×0.6

BE

30 ×0.9

CR

21 ×0.7

MB

0 ×0.0

PPCH

Citations per year, relative to Yu Jen Jan Yu Jen Jan (= 1×) peers Erin Emmons

Countries citing papers authored by Yu Jen Jan

Since Specialization

Citations

This map shows the geographic impact of Yu Jen Jan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Jen Jan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Jen Jan more than expected).

Fields of papers citing papers by Yu Jen Jan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Jen Jan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Jen Jan. The network helps show where Yu Jen Jan may publish in the future.

Co-authorship network of co-authors of Yu Jen Jan

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Jen Jan. A scholar is included among the top collaborators of Yu Jen Jan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Jen Jan. Yu Jen Jan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jan, Yu Jen, et al.. (2024). Body mass index and type 2 diabetes mellitus as metabolic determinants of immune checkpoint inhibitors response in melanoma. Journal for ImmunoTherapy of Cancer. 12(11). e009769–e009769. 1 indexed citations

2.

Cavassani, Karen A., Pai‐Chi Teng, Jie‐Fu Chen, et al.. (2021). Nuclear size of circulating tumor cells in advanced prostate cancer to reveal a potential biomarker for clinical outcomes and androgen receptor indifference.. Journal of Clinical Oncology. 39(6_suppl). 167–167. 1 indexed citations

3.

Teng, Pai‐Chi, Yu Jen Jan, Jie‐Fu Chen, et al.. (2020). Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy.. Journal of Clinical Oncology. 38(6_suppl). 170–170. 1 indexed citations

4.

Teng, Pai‐Chi, Yu Jen Jan, Minhyung Kim, et al.. (2020). Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50.. Journal of Clinical Oncology. 38(15_suppl). e17509–e17509. 1 indexed citations

5.

Teng, Pai‐Chi, Yu Jen Jan, Junhee Yoon, et al.. (2019). A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 37(15_suppl). 5059–5059. 1 indexed citations

6.

Chen, Pin‐Jung, Pai‐Chi Teng, Yazhen Zhu, et al.. (2019). Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Current Obstetrics and Gynecology Reports. 8(1). 1–8. 12 indexed citations

7.

Jan, Yu Jen, Jie‐Fu Chen, Yazhen Zhu, et al.. (2018). NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Advanced Drug Delivery Reviews. 125. 78–93. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact